European Heart Journal, Journal Year: 2024, Volume and Issue: unknown
Published: Sept. 10, 2024
Language: Английский
European Heart Journal, Journal Year: 2024, Volume and Issue: unknown
Published: Sept. 10, 2024
Language: Английский
Journal of Thrombosis and Thrombolysis, Journal Year: 2025, Volume and Issue: unknown
Published: April 21, 2025
Abstract miR-27a-3p targets several proteins on the coagulation cascade. The potential effect of direct oral anticoagulants (DOACs) treatment expression and their broader regulative anticoagulation is unknown. Fifty-nine atrial fibrillation patients treated with rivaroxaban ( n = 19), apixaban 27) or dabigatran 13), were included in study. was analyzed at baseline after 7 days DOAC therapy by using a predesigned TaqMan assay. Relative quantitation calculated compared pooled population different sample groups. did not alter (0.80 fold-change, p 0.486, population; 0.839 0.706, rivaroxaban; 0.921 0.800, apixaban; 0.733 0.540, dabigatran). differ between controls bleeding cases (0.833 0.588, baseline). Female had trend towards increased (1.564 0.177) reduced (0.683 0.243) to male patients. Despite regulatory role cascade, DOACs its expression. However, additional studies ethnic groups are necessary fully elucidate effect, if any, Graphical
Language: Английский
Citations
0Mitochondrion, Journal Year: 2025, Volume and Issue: 84, P. 102045 - 102045
Published: April 24, 2025
Language: Английский
Citations
0European Heart Journal, Journal Year: 2024, Volume and Issue: unknown
Published: Sept. 10, 2024
Language: Английский
Citations
0